Pulmonary hypertension: the hallmark of acute COVID-19 microvascular angiopathy?

Sri Harsha Dintakurti; Sanjana Kamath; Ciara Mahon; Suveer Singh; Bhavin Rawal; Simon P G Padley; Anand Devaraj; Laura C Price; Sujal R Desai; Tom Semple; Carole A Ridge

doi:10.1183/23120541.00389-2022

Pulmonary hypertension: the hallmark of acute COVID-19 microvascular angiopathy?

ERJ Open Res. 2023 Feb 6;9(1):00389-2022. doi: 10.1183/23120541.00389-2022. eCollection 2023 Jan.

Authors

Affiliations

¹ Imperial College London, London, UK.
² Department of Imaging, Royal Brompton Hospital, London, UK.
³ Department of Adult Intensive Care, Royal Brompton Hospital, London, UK.
⁴ Pulmonary Hypertension Service, Royal Brompton Hospital, London, UK.

Abstract

In situ pulmonary arterial thrombosis in COVID-19 is not visible on CTPA. However, the presence of CT-measured right heart and pulmonary artery dilatation in COVID-19 is likely attributable to this process and may be a possible surrogate for its detection. https://bit.ly/3g7z5TV.